menu
    • menu

    Company profile for HiFiBiO Therapeutics

    NEW Drugs in Dev: 4
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease. We integrate deep-rooted biological expertise with our comprehensive single-cell profiling technologies to rapidly discover and advance a pipeline of antibody drugs to treat cancer and autoimmune disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HiFiBiO TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    237 Putnam Ave, Cambridge, MA, 02139 USA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://hifibio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/hifibio/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/hifibio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fierce Biotech Names HiFiBiO Therapeutics a “Fierce 15” Biotech Company of 2023
    Fierce Biotech Names HiFiBiO Therapeutics a “Fierce 15” Biotech Company of 2023

    28 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230828615800/en

    BUSINESSWIRE
    28 Aug 2023
    Share Share
    HiFiBiO Therapeutics Announces First Patient Dosed with HFB200301
    HiFiBiO Therapeutics Announces First Patient Dosed with HFB200301

    23 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230623975562/en

    BUSINESSWIRE
    23 Jun 2023
    Share Share
    HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200603
    HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200603

    06 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230106005407/en

    BUSINESSWIRE
    06 Jan 2023
    Share Share
    HiFiBiO and Novartis to assess HFB200603 and tislelizumab combination
    HiFiBiO and Novartis to assess HFB200603 and tislelizumab combination

    21 Nov 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/hifibio-novartis-hfb200603-tislelizumab/

    CLINICALTRIALSARENA
    21 Nov 2022
    Share Share
    HiFiBiO Announces Clinical Trial Supply Agreement to Evaluate HFB200603
    HiFiBiO Announces Clinical Trial Supply Agreement to Evaluate HFB200603

    18 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221118005066/en

    BUSINESSWIRE
    18 Nov 2022
    Share Share
    HiFiBiO Announces Clinical Trial Supply Agreement to Evaluate HFB200301
    HiFiBiO Announces Clinical Trial Supply Agreement to Evaluate HFB200301

    15 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220815005154/en

    BUSINESSWIRE
    15 Aug 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search